Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 155CNS 39Genitourinary 28Gastrointestinal 26Lymphoid 19Myeloid 14Gynecologic 11Other solid neoplasm 9Dermatologic 8Head & Neck 7Endocrine 7Thoracic 6Other hematologic neoplasm 4Breast 3Plasma cell 1Other 1NET 1

Conditions

Mucositis 44Obesity 23Neoplasms 19Head and Neck Neoplasms 15Stomatitis 12Dyspnea 12Constipation 10Sexual Dysfunction, Physiological 8Squamous Cell Carcinoma of Head and Neck 7Breast Neoplasms 7Overweight 6Xerostomia 5Prostatic Neoplasms 5Radiation Injuries 4Opioid-Induced Constipation 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Pain 3Nausea 3Mouth Neoplasms 3Hematologic Neoplasms 3Colorectal Neoplasms 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Multiple Myeloma 2Mouth Diseases 2Leukemia 2Intestinal Diseases 2Infertility 2Febrile Neutropenia 2

Interventions

glucarpidase 1Methotrexate 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Osteosarcoma × Other × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡